Search Results - "Lotz, Gregor"

Refine Results
  1. 1

    Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo by Legleiter, Justin, Mitchell, Emily, Lotz, Gregor P., Sapp, Ellen, Ng, Cheping, DiFiglia, Marian, Thompson, Leslie M., Muchowski, Paul J.

    Published in The Journal of biological chemistry (07-05-2010)
    “…Huntington disease (HD) is caused by an expansion of more than 35–40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein, resulting in accumulation…”
    Get full text
    Journal Article
  2. 2

    The role of amyloidogenic protein oligomerization in neurodegenerative disease by Lotz, Gregor P., Legleiter, Justin

    “…A common pathological hallmark in many neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease, is the…”
    Get full text
    Journal Article
  3. 3

    Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models by Sontag, Emily Mitchell, Lotz, Gregor P, Agrawal, Namita, Tran, Andrew, Aron, Rebecca, Yang, Guocheng, Necula, Mihaela, Lau, Alice, Finkbeiner, Steven, Glabe, Charles, Marsh, J Lawrence, Muchowski, Paul J, Thompson, Leslie M

    Published in The Journal of neuroscience (08-08-2012)
    “…Huntington's disease (HD) is a devastating neurodegenerative disorder with no disease-modifying treatments available. The disease is caused by expansion of a…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening by Bidinosti, Michael, Shimshek, Derya R, Mollenhauer, Brit, Marcellin, David, Schweizer, Tatjana, Lotz, Gregor P, Schlossmacher, Michael G, Weiss, Andreas

    Published in The Journal of biological chemistry (28-09-2012)
    “…Familial Parkinson disease (PD) can result from α-synuclein gene multiplication, implicating the reduction of neuronal α-synuclein as a therapeutic target…”
    Get full text
    Journal Article
  8. 8

    Monoclonal Antibodies Recognize Distinct Conformational Epitopes Formed by Polyglutamine in a Mutant Huntingtin Fragment by Legleiter, Justin, Lotz, Gregor P., Miller, Jason, Ko, Jan, Ng, Cheping, Williams, Geneva L., Finkbeiner, Steve, Patterson, Paul H., Muchowski, Paul J.

    Published in The Journal of biological chemistry (07-08-2009)
    “…Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (polyQ) domain in the N-terminal region of huntingtin (htt)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle by Lotz, Gregor P., Legleiter, Justin, Aron, Rebecca, Mitchell, Emily J., Huang, Shao-Yi, Ng, Cheping, Glabe, Charles, Thompson, Leslie M., Muchowski, Paul J.

    Published in The Journal of biological chemistry (03-12-2010)
    “…Inclusion bodies of aggregated mutant huntingtin (htt) fragments are a neuropathological hallmark of Huntington disease (HD). The molecular chaperones Hsp70…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Opportunities and Challenges for Molecular Chaperone Modulation to Treat Protein-Conformational Brain Diseases by van der Putten, Herman, Lotz, Gregor P.

    Published in Neurotherapeutics (01-07-2013)
    “…A common pathological hallmark of protein-conformational brain diseases is the formation of disease-specific protein aggregates. In Alzheimer’s disease, these…”
    Get full text
    Journal Article
  14. 14

    Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease by Wacker, Jennifer L, Huang, Shao-Yi, Steele, Andrew D, Aron, Rebecca, Lotz, Gregor P, Nguyen, QuangVu, Giorgini, Flaviano, Roberson, Erik D, Lindquist, Susan, Masliah, Eliezer, Muchowski, Paul J

    Published in The Journal of neuroscience (15-07-2009)
    “…Endogenous protein quality control machinery has long been suspected of influencing the onset and progression of neurodegenerative diseases characterized by…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Aha1 Binds to the Middle Domain of Hsp90, Contributes to Client Protein Activation, and Stimulates the ATPase Activity of the Molecular Chaperone by Lotz, Gregor P., Lin, Hongying, Harst, Anja, Obermann, Wolfgang M.J.

    Published in The Journal of biological chemistry (09-05-2003)
    “…The ATP-dependent molecular chaperone Hsp90 is an essential and abundant stress protein in the eukaryotic cytosol that cooperates with a cohort of…”
    Get full text
    Journal Article
  17. 17

    European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticals by Tourdot, Sophie, Quaglia, Carolina B, Chamberlain, Paul, De Groot, Anne S, Dellas, Nikki, Guillemare, Eric, Kromminga, Arno, Lotz, Gregor P, Mingozzi, Federico, Piccoli, Luca, Pine, Samuel, Richards, Susan, Waxenecker, Günter, Kramer, Daniel

    Published in Bioanalysis (01-08-2020)
    “…Given the expanding number of complex therapeutic protein drugs and advanced therapy medicinal products that are being developed, improving our ability to…”
    Get full text
    Journal Article
  18. 18

    novel HSP90 chaperone complex regulates intracellular vesicle transport by Lotz, Gregor P, Brychzy, Alexander, Heinz, Stefan, Obermann, Wolfgang M.J

    Published in Journal of cell science (01-03-2008)
    “…Heat shock protein 90 (HSP90) is considered a specialized molecular chaperone that controls the folding of cell-regulatory proteins such as steroid receptors…”
    Get full text
    Journal Article
  19. 19

    Immuno-based detection assays to quantify distinct mutant huntingtin conformations in biological samples by Lotz, Gregor P, Weiss, Andreas

    “…A pathological hallmark of many protein-misfolding diseases is the formation of insoluble aggregates. Quantitative methods are needed to better resolve and…”
    Get more information
    Journal Article
  20. 20